MiR-210 inhibits NF-ΰ B signaling pathway by targeting DR6 in osteoarthritis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Dawei ^a   Cao, Xiaorui ^a   Li, Jun ^a   Zhao, Guangyue ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MICRORNA; MIRN210 MICRORNA, RAT; TUMOR NECROSIS FACTOR RECEPTOR;

3' UNTRANSLATED REGION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

3' UNTRANSLATED REGIONS; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICRORNAS; NF-KAPPA B; OSTEOARTHRITIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 84938944350     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12775     Document Type: Article

References (30)

1. Taruc-Uy, R. L. & Lynch, S. A. Diagnosis and treatment of osteoarthritis. Prim Care. 40, 821-836, vii (2013).
2. Lotz, M. K. & Kraus, V. B. New developments in osteoarthritis. Posttraumatic osteoarthritis: Pathogenesis and pharmacological treatment options. Arthritis Res Ther. 12, 211 (2010).
3. Sun, W. et al. microRNA: A master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng. 12, 1-27 (2010).
4. Croce, C. M. & Calin, G. A. miRNAs, cancer, and stem cell division. Cell. 122, 6-7 (2005).
5. Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science. 303, 83-86 (2004).
6. Esquela-Kerscher, A. & Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6, 259-269 (2006).
7. Van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 103, 18255-18260 (2006).
8. Poy, M. N. et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 432, 226-230 (2004).
9. Nakasa, T. et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 58, 1284-1292 (2008).
10. Stanczyk, J. et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58, 1001-1009(2008).
11. Wu, C. et al. MicroRNAs play a role in chondrogenesis and osteoarthritis (review). Int J Mol Med. 34, 13-23 (2014).
12. Yamasaki, K. et al. Angiogenic microRNA-210 is present in cells surrounding osteonecrosis. J Orthop Res. 30, 1263-1270 (2012).
13. Qi, J., et al. microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-kappaB1 in murine macrophages. FEBS Lett. 586, 1201-1207 (2012).
14. Olarerin-George, A. O. et al. A functional genomics screen for microRNA regulators of NF-kappaB signaling. BMC Biol. 11, 19 (2013).
15. Hayden, M. S., West, A. P. & Ghosh, S. NF-kappaB and the immune response. Oncogene. 25, 6758-6780 (2006).
16. Gerondakis, S. et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene. 25, 6781-6799(2006).
17. Ma, X., Becker Buscaglia, L. E., Barker, J. R. & Li, Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 3, 159-166 (2011).
18. Pan, G. et al. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett. 431, 351-356 (1998).
19. Karlsson, C. et al. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage. 18, 581-592 (2010).
20. Rainbow, R., Ren, W. & Zeng, L. Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches. Arthritis. 2012, 741582 (2012).
21. Miyaki, S. et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 24, 1173-1185 (2010).
22. Zhang, Y. et al. MicroRNA-21 controls the development of osteoarthritis by targeting GDF-5 in chondrocytes. Exp Mol Med. 46, e79 (2014).
23. Zhang, Y. et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: New insights into molecular mechanisms for the disease. J Cell Mol Med. 16, 249-259 (2012).
24. O'Neill, L. A., Sheedy, F. J. & McCoy, C. E. MicroRNAs: The fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 11, 163-175 (2011).
25. Qiu, J. et al. Neuroprotective effects of microRNA-210 on hypoxic-ischemic encephalopathy. Biomed Res Int. 2013, 350419 (2013).
26. Li, L. et al. Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis. Int J Oncol. 44, 2111-2120 (2014).
27. Kim, J. H. et al. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis. 4, e588 (2013).
28. Jones, S. W. et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage. 17, 464-472 (2009).
29. Cinar, B. M. et al. Intra-articular zoledronic acid in a rat osteoarthritis model: Significant reduced synovitis may indicate chondroprotective effect. Knee Surg Sports Traumatol Arthrosc. 23, 1410-1418 (2015).
30. Kosinska, M. K. et al. A lipidomic study of phospholipid classes and species in human synovial fluid. Arthritis Rheum. 65, 2323-2333 (2013).